Wellington Management Group LLP Lowers Holdings in Humana Inc. (NYSE:HUM)

Wellington Management Group LLP trimmed its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 44.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 2,570,439 shares of the insurance provider's stock after selling 2,020,721 shares during the period. Wellington Management Group LLP owned approximately 2.13% of Humana worth $652,146,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in HUM. Vanguard Group Inc. raised its holdings in Humana by 15.8% in the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after buying an additional 1,751,857 shares during the last quarter. State Street Corp increased its position in shares of Humana by 1.0% during the third quarter. State Street Corp now owns 5,357,420 shares of the insurance provider's stock valued at $1,701,582,000 after acquiring an additional 53,272 shares in the last quarter. Pzena Investment Management LLC raised its holdings in Humana by 44.0% in the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after acquiring an additional 1,103,132 shares during the last quarter. Norges Bank bought a new position in Humana in the 4th quarter valued at approximately $416,202,000. Finally, Boston Partners lifted its position in Humana by 435.8% in the 4th quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock valued at $279,236,000 after acquiring an additional 893,637 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Price Performance

Shares of Humana stock traded down $1.13 on Thursday, hitting $264.67. 1,808,672 shares of the company were exchanged, compared to its average volume of 1,722,925. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $31.94 billion, a price-to-earnings ratio of 26.60, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. The company has a 50-day moving average price of $268.97 and a 200 day moving average price of $272.62.

Remove Ads

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, sell-side analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date is Friday, March 28th. Humana's dividend payout ratio (DPR) is 35.58%.

Analyst Ratings Changes

HUM has been the subject of several research reports. Truist Financial boosted their price objective on shares of Humana from $260.00 to $290.00 and gave the company a "hold" rating in a report on Monday, January 6th. Royal Bank of Canada reissued an "outperform" rating and set a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Piper Sandler lifted their price objective on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a report on Wednesday, January 15th. StockNews.com cut Humana from a "buy" rating to a "hold" rating in a research report on Tuesday, March 18th. Finally, JPMorgan Chase & Co. dropped their target price on Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research report on Tuesday, February 18th. Eighteen equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $285.68.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.